Skip to main content
Toggle navigation
Home
About ACSH
Media/Contact
Our Team
Financials
Donate
Publications
Subscribe
Write for us
You must enable JavaScript to view the search results.
Home
About
About ACSH
Our Team
Financials
Donate
Publications
All Publications
Priorities Magazine Spring 2018
The Next Plague and How Science Will Stop It
Priorities Magazine Winter 2018
Priorities Magazine Fall 2017
Little Black Book of Junk Science
Priorities Magazine Winter 2017
Should You Worry About Artificial Flavors Or Colors?
Should You Worry About Artificial Sweeteners?
Summer Health and Safety Tips
How Toxic Terrorists Scare You With Science Terms
Adult Immunization: The Need for Enhanced Utilization
Should You Worry About Salt?
Priorities Magazine Spring 2016
IARC Diesel Exhaust & Lung Cancer: An Analysis
Teflon and Human Health: Do the Charges Stick?
Helping Smokers Quit: The Science Behind Tobacco Harm Reduction
Irradiated Foods
Foods Are Not Cigarettes: Why Tobacco Lawsuits Are Not a Model for Obesity Lawsuits
The Prevention and Treatment of Osteoporosis: A Review
Are "Low Dose" Health Effects of Chemicals Real?
The Effects of Nicotine on Human Health
Traditional Holiday Dinner Replete with Natural Carcinogens - Even Organic Thanksgiving Dinners
A Primer On Dental Care: Quality and Quackery
Nuclear Energy and Health And the Benefits of Low-Dose Radiation Hormesis
Priorities in Caring for Your Children: A Primer for Parents
Endocrine Disrupters: A Scientific Perspective
Good Stories, Bad Science: A Guide for Journalists to the Health Claims of "Consumer Activist" Groups
A Comparison of the Health Effects of Alcohol Consumption and Tobacco Use in America
Moderate Alcohol Consumption and Health
Irradiated Foods Fifth Edition
Media/Contact
Subscribe
Write For Us
Ridgeback Therapeutics
Ridgeback's Molnupiravir (EIDD-2801) 'Appears to Stop SARS-CoV-2 in Its Tracks.' Or Does It?
A Medscape article entitled "Five-Day Course of Oral Antiviral Appears to Stop SARS-CoV-2 in Its Tracks" was recently published. Don't fall for the title. It's not that simple.
Read more
